Ayer has sold around half of the three million shares they acquired in the recent offering. 1.5 million shares sold at a profit of around $3 a share after just two months was obviously too good an opportunity for them to pass up. One wonders if their bonuses are awarded on the basis of full-year profits.
I'll give it to Ayer.They reversed a normal biotechnique and more than likely have recouped all their investment.
Its no coincidence that Ayer sold 1.6 Million of their shares.....they now own 4.92% which frees them from SEC req of 5% owners.
Willie the hedge fund President I guarantee was in full knowledge of Ayers move. Call the SEC!
Was saying to somebody only this morning that while investors in development biotech stocks such as INSM must be prepared for share price volatility, one expects a fair degree of stability when buying a stock like AAPL. It wasn't that long ago that the share price topped $700 - it had dropped to around $520 at one point this week.